NCT06548672 : Clinical Trial Detail - Cancer Knowledgebase (CKB)

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT06548672
Title	A Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or Metastatic Cancer
Recruitment	Recruiting
Gender	both
Phase	Phase I
Variant Requirements	No
Sponsors	Biocity Biopharmaceutics Co., Ltd.
Indications	breast cancer prostate cancer ovarian cancer colorectal cancer endometrial cancer esophagus squamous cell carcinoma lung non-small cell carcinoma pancreatic cancer head and neck squamous cell carcinoma Advanced Solid Tumor transitional cell carcinoma
Therapies	BC3195
Age Groups:	adult \| senior
Covered Countries	USA

NCT06548672
Clinical Trial Detail